Wed, January 8, 2025
Tue, January 7, 2025
Mon, January 6, 2025
Sun, January 5, 2025
Sat, January 4, 2025
Fri, January 3, 2025
[ Fri, Jan 03rd ] - MSN
3 Vanguard ETFs to Buy in 2025
Thu, January 2, 2025
Wed, January 1, 2025
Tue, December 31, 2024
Mon, December 30, 2024
Sun, December 29, 2024
[ Sun, Dec 29th 2024 ] - Forbes
5 Top Index Funds To Buy For 2025
Sat, December 28, 2024
Fri, December 27, 2024
Thu, December 26, 2024
Wed, December 25, 2024
Tue, December 24, 2024
Fri, December 20, 2024
Thu, December 19, 2024
[ Thu, Dec 19th 2024 ] - Forbes
13 Must-Read Investing Books
[ Thu, Dec 19th 2024 ] - Forbes
PepsiCo Is Oversold

Why Is Geron Corporation (GERN) Among the Best Biotech Penny Stocks to Invest in Now?


//stocks-investing.news-articles.net/content/202 .. -best-biotech-penny-stocks-to-invest-in-now.html
Published in Stocks and Investing on Tuesday, December 31st 2024 at 13:01 GMT by MSN   Print publication without navigation

  • We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has ...

The article from MSN Money discusses why Geron Corporation (GERN) is considered one of the best biotech penny stocks to invest in currently. Geron is highlighted for its focus on developing treatments for hematologic malignancies, particularly its lead drug candidate, imetelstat, which is in late-stage clinical trials for treating lower risk myelodysplastic syndromes (MDS) and relapsed/refractory myelofibrosis. The potential of imetelstat to address unmet medical needs in these conditions has sparked investor interest. Additionally, Geron's recent positive clinical trial results, its strategic partnerships, and the anticipation of upcoming FDA decisions contribute to its appeal. The article also notes the inherent risks of investing in penny stocks, such as high volatility and the speculative nature of biotech investments, but suggests that Geron's promising pipeline and the potential for significant returns if imetelstat gains approval make it an attractive option for those willing to take on the risk.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/why-is-geron-corporation-gern-among-the-best-biotech-penny-stocks-to-invest-in-now/ar-AA1wLWL4 ]

Publication Contributing Sources